title,geo_accession,status,submission_date,last_update_date,type,channel_count,source_name_ch1,organism_ch1,characteristics_ch1,characteristics_ch1.1,characteristics_ch1.2,characteristics_ch1.3,characteristics_ch1.4,characteristics_ch1.5,characteristics_ch1.6,characteristics_ch1.7,characteristics_ch1.8,characteristics_ch1.9,characteristics_ch1.10,characteristics_ch1.11,characteristics_ch1.12,characteristics_ch1.13,characteristics_ch1.14,characteristics_ch1.15,molecule_ch1,extract_protocol_ch1,label_ch1,label_protocol_ch1,taxid_ch1,hyb_protocol,scan_protocol,description,description.1,description.2,data_processing,platform_id,contact_name,contact_email,contact_phone,contact_fax,contact_laboratory,contact_department,contact_institute,contact_address,contact_city,contact_state,contact_zip/postal_code,contact_country,supplementary_file,supplementary_file.1,data_row_count,relation,relation.1,age at dx:ch1,all lymph nodes:ch1,binary 5y met event:ch1,bm event:ch1,bmfs (yr):ch1,her2 status:ch1,lm event:ch1,lmfs (yr):ch1,met event:ch1,mfs (yr):ch1,name:ch1,path er status:ch1,path pr status:ch1,pos lymph nodes:ch1,tissue type:ch1,tumor size (cm):ch1,van't veer signature:ch1,
GSM50034,B110-T,GSM50034,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B110-T,age at dx: 61,tumor size (cm): 2.2,pos lymph nodes: 2,all lymph nodes: 11,path er status: N,path pr status: N,her2 status: 3+,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.25,lm event: 0,lmfs (yr): 7.25,bm event: 0,bmfs (yr): 7.25,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50034/suppl/GSM50034.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50034/suppl/GSM50034.EXP.gz,22283,Reanalyzed by: GSE47561,,61,11,0,0,7.25,3+,0,7.25,0,7.25,B110-T,N,N,2,NA,2.2,Good Prognosis
GSM50035,B114-T,GSM50035,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B114-T,age at dx: 61,tumor size (cm): 3.8,pos lymph nodes: 3,all lymph nodes: 19,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 1.84,lm event: 1,lmfs (yr): 1.84,bm event: 0,bmfs (yr): 1.84,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50035/suppl/GSM50035.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50035/suppl/GSM50035.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,61,19,1,0,1.84,N,1,1.84,1,1.84,B114-T,N,N,3,NA,3.8,Bad Prognosis
GSM50036,B52-T,GSM50036,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B52-T,age at dx: 40,tumor size (cm): 3,pos lymph nodes: 0,all lymph nodes: 19,path er status: P,path pr status: P,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 9.15,lm event: 0,lmfs (yr): 9.15,bm event: 0,bmfs (yr): 9.15,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50036/suppl/GSM50036.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50036/suppl/GSM50036.EXP.gz,22283,Reanalyzed by: GSE47561,,40,19,0,0,9.15,N,0,9.15,0,9.15,B52-T,P,P,0,NA,3,Bad Prognosis
GSM50037,B54-T,GSM50037,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B54-T,age at dx: 40,tumor size (cm): 2.8,pos lymph nodes: 0,all lymph nodes: 26,path er status: P,path pr status: P,her2 status: --,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.86,lm event: 0,lmfs (yr): 6.86,bm event: 0,bmfs (yr): 6.86,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50037/suppl/GSM50037.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50037/suppl/GSM50037.EXP.gz,22283,Reanalyzed by: GSE47561,,40,26,0,0,6.86,--,0,6.86,0,6.86,B54-T,P,P,0,NA,2.8,Good Prognosis
GSM50038,B55-T,GSM50038,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B55-T,age at dx: 75,tumor size (cm): 2.2,pos lymph nodes: 0,all lymph nodes: 15,path er status: P,path pr status: N,her2 status: 1+,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.47,lm event: 0,lmfs (yr): 6.47,bm event: 0,bmfs (yr): 6.47,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50038/suppl/GSM50038.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50038/suppl/GSM50038.EXP.gz,22283,Reanalyzed by: GSE47561,,75,15,0,0,6.47,1+,0,6.47,0,6.47,B55-T,P,N,0,NA,2.2,Good Prognosis
GSM50039,B56-T,GSM50039,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B56-T,age at dx: 55,tumor size (cm): 2.1,pos lymph nodes: 0,all lymph nodes: 19,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.08,lm event: 0,lmfs (yr): 7.08,bm event: 0,bmfs (yr): 7.08,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50039/suppl/GSM50039.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50039/suppl/GSM50039.EXP.gz,22283,Reanalyzed by: GSE47561,,55,19,0,0,7.08,N,0,7.08,0,7.08,B56-T,P,P,0,NA,2.1,Good Prognosis
GSM50040,B57-T,GSM50040,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B57-T,age at dx: 57,tumor size (cm): 2.8,pos lymph nodes: 0,all lymph nodes: 19,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.57,lm event: 0,lmfs (yr): 7.57,bm event: 0,bmfs (yr): 7.57,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50040/suppl/GSM50040.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50040/suppl/GSM50040.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,57,19,0,0,7.57,N,0,7.57,0,7.57,B57-T,N,N,0,NA,2.8,Bad Prognosis
GSM50041,B59-T,GSM50041,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B59-T,age at dx: 73,tumor size (cm): 3.5,pos lymph nodes: 0,all lymph nodes: 9,path er status: N,path pr status: ?,her2 status: --,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50041/suppl/GSM50041.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50041/suppl/GSM50041.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,73,9,--,--,--,--,--,--,--,--,B59-T,N,?,0,NA,3.5,--
GSM50042,B61-T,GSM50042,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B61-T,age at dx: 73,tumor size (cm): 3.5,pos lymph nodes: 0,all lymph nodes: 35,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 4.41,lm event: 0,lmfs (yr): 4.41,bm event: 0,bmfs (yr): 4.41,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50042/suppl/GSM50042.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50042/suppl/GSM50042.EXP.gz,22283,Reanalyzed by: GSE47561,,73,35,--,0,4.41,N,0,4.41,0,4.41,B61-T,N,N,0,NA,3.5,Bad Prognosis
GSM50043,B62-T,GSM50043,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B62-T,age at dx: 63,tumor size (cm): 5,pos lymph nodes: 0,all lymph nodes: 15,path er status: P,path pr status: N,her2 status: 1+,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 5.23,lm event: 0,lmfs (yr): 5.23,bm event: 0,bmfs (yr): 5.23,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50043/suppl/GSM50043.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50043/suppl/GSM50043.EXP.gz,22283,Reanalyzed by: GSE47561,,63,15,0,0,5.23,1+,0,5.23,0,5.23,B62-T,P,N,0,NA,5,Good Prognosis
GSM50044,B63-T,GSM50044,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B63-T,age at dx: 64,tumor size (cm): 3.2,pos lymph nodes: 0,all lymph nodes: 27,path er status: P,path pr status: N,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 5.62,lm event: 0,lmfs (yr): 5.62,bm event: 0,bmfs (yr): 5.62,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50044/suppl/GSM50044.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50044/suppl/GSM50044.EXP.gz,22283,Reanalyzed by: GSE47561,,64,27,0,0,5.62,N,0,5.62,0,5.62,B63-T,P,N,0,NA,3.2,Good Prognosis
GSM50045,B66-T,GSM50045,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B66-T,age at dx: 58,tumor size (cm): 2.8,pos lymph nodes: 0,all lymph nodes: 31,path er status: N,path pr status: N,her2 status: --,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 10.75,lm event: 0,lmfs (yr): 10.75,bm event: 0,bmfs (yr): 10.75,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50045/suppl/GSM50045.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50045/suppl/GSM50045.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,58,31,0,0,10.75,--,0,10.75,0,10.75,B66-T,N,N,0,NA,2.8,Bad Prognosis
GSM50046,B67-T,GSM50046,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B67-T,age at dx: 32,tumor size (cm): 1.8,pos lymph nodes: 0,all lymph nodes: 18,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 8.04,lm event: 0,lmfs (yr): 8.04,bm event: 0,bmfs (yr): 8.04,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50046/suppl/GSM50046.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50046/suppl/GSM50046.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,32,18,0,0,8.04,N,0,8.04,0,8.04,B67-T,N,N,0,NA,1.8,Bad Prognosis
GSM50047,B68-T,GSM50047,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B68-T,age at dx: 86,tumor size (cm): 3.2,pos lymph nodes: 0,all lymph nodes: 18,path er status: P,path pr status: P,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 5.41,lm event: 0,lmfs (yr): 5.41,bm event: 0,bmfs (yr): 5.41,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50047/suppl/GSM50047.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50047/suppl/GSM50047.EXP.gz,22283,Reanalyzed by: GSE47561,,86,18,0,0,5.41,N,0,5.41,0,5.41,B68-T,P,P,0,NA,3.2,Bad Prognosis
GSM50048,B69-T,GSM50048,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B69-T,age at dx: 49,tumor size (cm): 1.5,pos lymph nodes: 0,all lymph nodes: 6,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.07,lm event: 0,lmfs (yr): 6.07,bm event: 0,bmfs (yr): 6.07,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50048/suppl/GSM50048.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50048/suppl/GSM50048.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,49,6,0,0,6.07,N,0,6.07,0,6.07,B69-T,N,N,0,NA,1.5,Bad Prognosis
GSM50049,B71-T,GSM50049,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B71-T,age at dx: 46,tumor size (cm): 2.1,pos lymph nodes: 0,all lymph nodes: 18,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 5.50,lm event: 0,lmfs (yr): 5.50,bm event: 0,bmfs (yr): 5.50,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50049/suppl/GSM50049.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50049/suppl/GSM50049.EXP.gz,22283,Reanalyzed by: GSE47561,,46,18,0,0,5.50,N,0,5.50,0,5.50,B71-T,P,P,0,NA,2.1,Good Prognosis
GSM50050,B72-T,GSM50050,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B72-T,age at dx: 63,tumor size (cm): 1.1,pos lymph nodes: 0,all lymph nodes: 18,path er status: N,path pr status: N,her2 status: --,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50050/suppl/GSM50050.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50050/suppl/GSM50050.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,63,18,--,--,--,--,--,--,--,--,B72-T,N,N,0,NA,1.1,--
GSM50051,B74-T,GSM50051,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B74-T,age at dx: 49,tumor size (cm): 6,pos lymph nodes: 0,all lymph nodes: 21,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 3.77,lm event: 0,lmfs (yr): 3.77,bm event: 0,bmfs (yr): 3.77,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50051/suppl/GSM50051.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50051/suppl/GSM50051.EXP.gz,22283,Reanalyzed by: GSE47561,,49,21,--,0,3.77,N,0,3.77,0,3.77,B74-T,P,P,0,NA,6,Good Prognosis
GSM50052,B75-T,GSM50052,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B75-T,age at dx: 47,tumor size (cm): 5,pos lymph nodes: 0,all lymph nodes: 8,path er status: N,path pr status: N,her2 status: 0-1,van't veer signature: Bad Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 4.56,lm event: 0,lmfs (yr): 4.56,bm event: 0,bmfs (yr): 4.56,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50052/suppl/GSM50052.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50052/suppl/GSM50052.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,47,8,--,0,4.56,0-1,0,4.56,0,4.56,B75-T,N,N,0,NA,5,Bad Prognosis
GSM50053,B76-T,GSM50053,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B76-T,age at dx: 82,tumor size (cm): 2,pos lymph nodes: 0,all lymph nodes: 3,path er status: P,path pr status: P,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 3.97,lm event: 0,lmfs (yr): 3.97,bm event: 0,bmfs (yr): 3.97,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50053/suppl/GSM50053.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50053/suppl/GSM50053.EXP.gz,22283,Reanalyzed by: GSE47561,,82,3,--,0,3.97,N,0,3.97,0,3.97,B76-T,P,P,0,NA,2,Bad Prognosis
GSM50054,B77-T,GSM50054,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B77-T,age at dx: 73,tumor size (cm): 3,pos lymph nodes: 0,all lymph nodes: 16,path er status: N,path pr status: N,her2 status: 0-1,van't veer signature: Bad Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 4.05,lm event: 0,lmfs (yr): 4.05,bm event: 0,bmfs (yr): 4.05,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50054/suppl/GSM50054.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50054/suppl/GSM50054.EXP.gz,22283,Reanalyzed by: GSE47561,,73,16,--,0,4.05,0-1,0,4.05,0,4.05,B77-T,N,N,0,NA,3,Bad Prognosis
GSM50055,B53-T,GSM50055,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B53-T,age at dx: 33,tumor size (cm): 3.5,pos lymph nodes: 0,all lymph nodes: 15,path er status: N,path pr status: N,her2 status: 0-1,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50055/suppl/GSM50055.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50055/suppl/GSM50055.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,33,15,--,--,--,0-1,--,--,--,--,B53-T,N,N,0,NA,3.5,--
GSM50056,B58-T,GSM50056,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B58-T,age at dx: 70,tumor size (cm): 5,pos lymph nodes: 0,all lymph nodes: 26,path er status: P,path pr status: N,her2 status: --,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50056/suppl/GSM50056.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50056/suppl/GSM50056.EXP.gz,22283,Reanalyzed by: GSE47561,,70,26,--,--,--,--,--,--,--,--,B58-T,P,N,0,NA,5,--
GSM50057,B60-T,GSM50057,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B60-T,age at dx: 46,tumor size (cm): 4,pos lymph nodes: 0,all lymph nodes: 39,path er status: N,path pr status: N,her2 status: 3+,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50057/suppl/GSM50057.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50057/suppl/GSM50057.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,46,39,--,--,--,3+,--,--,--,--,B60-T,N,N,0,NA,4,--
GSM50058,B70-T,GSM50058,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B70-T,age at dx: 51,tumor size (cm): 4,pos lymph nodes: 0,all lymph nodes: 16,path er status: N,path pr status: N,her2 status: 2+,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50058/suppl/GSM50058.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50058/suppl/GSM50058.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,51,16,--,--,--,2+,--,--,--,--,B70-T,N,N,0,NA,4,--
GSM50059,B42-T,GSM50059,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B42-T,age at dx: 73,tumor size (cm): 2.9,pos lymph nodes: 0,all lymph nodes: 16,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.63,lm event: 0,lmfs (yr): 7.63,bm event: 0,bmfs (yr): 7.63,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50059/suppl/GSM50059.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50059/suppl/GSM50059.EXP.gz,22283,Reanalyzed by: GSE47561,,73,16,0,0,7.63,N,0,7.63,0,7.63,B42-T,P,P,0,NA,2.9,Good Prognosis
GSM50060,B43-T,GSM50060,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B43-T,age at dx: 52,tumor size (cm): 4.5,pos lymph nodes: 0,all lymph nodes: 26,path er status: N,path pr status: N,her2 status: 1+,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 3.47,lm event: 1,lmfs (yr): 3.47,bm event: 0,bmfs (yr): 4.62,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50060/suppl/GSM50060.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50060/suppl/GSM50060.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,52,26,1,0,4.62,1+,1,3.47,1,3.47,B43-T,N,N,0,NA,4.5,Bad Prognosis
GSM50061,B44-T,GSM50061,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B44-T,age at dx: 61,tumor size (cm): 6,pos lymph nodes: 0,all lymph nodes: 26,path er status: N,path pr status: N,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 3.96,lm event: 1,lmfs (yr): 3.96,bm event: 1,bmfs (yr): 3.96,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50061/suppl/GSM50061.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50061/suppl/GSM50061.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,61,26,1,1,3.96,N,1,3.96,1,3.96,B44-T,N,N,0,NA,6,Good Prognosis
GSM50062,B45-T,GSM50062,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B45-T,age at dx: 68,tumor size (cm): 3.5,pos lymph nodes: 0,all lymph nodes: 23,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 3.07,lm event: 0,lmfs (yr): 6.17,bm event: 0,bmfs (yr): 6.17,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50062/suppl/GSM50062.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50062/suppl/GSM50062.EXP.gz,22283,Reanalyzed by: GSE47561,,68,23,1,0,6.17,N,0,6.17,1,3.07,B45-T,P,P,0,NA,3.5,Good Prognosis
GSM50063,B46-T,GSM50063,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B46-T,age at dx: 49,tumor size (cm): 3.2,pos lymph nodes: 0,all lymph nodes: 36,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 3.11,lm event: 1,lmfs (yr): 3.11,bm event: 0,bmfs (yr): 5.71,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50063/suppl/GSM50063.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50063/suppl/GSM50063.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,49,36,1,0,5.71,N,1,3.11,1,3.11,B46-T,N,N,0,NA,3.2,Bad Prognosis
GSM50064,B47-T,GSM50064,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B47-T,age at dx: 70,tumor size (cm): 6.5,pos lymph nodes: 0,all lymph nodes: 14,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 0.94,lm event: 1,lmfs (yr): 1.34,bm event: 1,bmfs (yr): 0.94,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50064/suppl/GSM50064.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50064/suppl/GSM50064.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,70,14,1,1,0.94,N,1,1.34,1,0.94,B47-T,N,N,0,NA,6.5,Bad Prognosis
GSM50065,B48-T,GSM50065,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B48-T,age at dx: 54,tumor size (cm): 3,pos lymph nodes: 0,all lymph nodes: 11,path er status: P,path pr status: N,her2 status: 3+,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 5.81,lm event: 0,lmfs (yr): 5.81,bm event: 0,bmfs (yr): 5.81,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50065/suppl/GSM50065.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50065/suppl/GSM50065.EXP.gz,22283,Reanalyzed by: GSE47561,,54,11,0,0,5.81,3+,0,5.81,0,5.81,B48-T,P,N,0,NA,3,Bad Prognosis
GSM50066,B49-T,GSM50066,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B49-T,age at dx: 80,tumor size (cm): 2,pos lymph nodes: 0,all lymph nodes: 4,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 1.24,lm event: 1,lmfs (yr): 1.24,bm event: 1,bmfs (yr): 1.24,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50066/suppl/GSM50066.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50066/suppl/GSM50066.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,80,4,1,1,1.24,N,1,1.24,1,1.24,B49-T,N,N,0,NA,2,Bad Prognosis
GSM50067,B50-T,GSM50067,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B50-T,age at dx: 78,tumor size (cm): 3,pos lymph nodes: 0,all lymph nodes: 2,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 0.77,lm event: 1,lmfs (yr): 0.77,bm event: 0,bmfs (yr): 0.95,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50067/suppl/GSM50067.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50067/suppl/GSM50067.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,78,2,1,0,0.95,N,1,0.77,1,0.77,B50-T,N,N,0,NA,3,Bad Prognosis
GSM50068,B51-T,GSM50068,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B51-T,age at dx: 57,tumor size (cm): 1.7,pos lymph nodes: 0,all lymph nodes: 17,path er status: P,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 3.48,lm event: 1,lmfs (yr): 3.48,bm event: 0,bmfs (yr): 6.01,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50068/suppl/GSM50068.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50068/suppl/GSM50068.EXP.gz,22283,Reanalyzed by: GSE47561,,57,17,1,0,6.01,N,1,3.48,1,3.48,B51-T,P,N,0,NA,1.7,Bad Prognosis
GSM50069,B73-T,GSM50069,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B73-T,age at dx: 73,tumor size (cm): 3.2,pos lymph nodes: 0,all lymph nodes: 17,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 3.83,lm event: 1,lmfs (yr): 3.83,bm event: 0,bmfs (yr): 4.01,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50069/suppl/GSM50069.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50069/suppl/GSM50069.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,73,17,1,0,4.01,N,1,3.83,1,3.83,B73-T,N,N,0,NA,3.2,Bad Prognosis
GSM50070,B98-T,GSM50070,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B98-T,age at dx: 58,tumor size (cm): 2,pos lymph nodes: 3,all lymph nodes: 16,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 3.36,lm event: 0,lmfs (yr): 6.96,bm event: 1,bmfs (yr): 3.36,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50070/suppl/GSM50070.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50070/suppl/GSM50070.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,58,16,1,1,3.36,N,0,6.96,1,3.36,B98-T,N,N,3,NA,2,Bad Prognosis
GSM50071,B100-T,GSM50071,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B100-T,age at dx: 78,tumor size (cm): 2.5,pos lymph nodes: 2,all lymph nodes: 14,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 5.82,lm event: 0,lmfs (yr): 5.82,bm event: 0,bmfs (yr): 5.82,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Fehler:509,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50071/suppl/GSM50071.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50071/suppl/GSM50071.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,78,14,0,0,5.82,N,0,5.82,0,5.82,B100-T,N,N,2,NA,2.5,Bad Prognosis
GSM50072,B101-T,GSM50072,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B101-T,age at dx: 47,tumor size (cm): 3.5,pos lymph nodes: 2,all lymph nodes: 26,path er status: N,path pr status: N,her2 status: 3+,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 10.74,lm event: 0,lmfs (yr): 10.74,bm event: 0,bmfs (yr): 10.74,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50072/suppl/GSM50072.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50072/suppl/GSM50072.EXP.gz,22283,Reanalyzed by: GSE47561,,47,26,0,0,10.74,3+,0,10.74,0,10.74,B101-T,N,N,2,NA,3.5,Bad Prognosis
GSM50073,B102-T,GSM50073,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B102-T,age at dx: 50,tumor size (cm): 4,pos lymph nodes: 2,all lymph nodes: 29,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.25,lm event: 0,lmfs (yr): 7.25,bm event: 0,bmfs (yr): 7.25,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50073/suppl/GSM50073.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50073/suppl/GSM50073.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,50,29,0,0,7.25,N,0,7.25,0,7.25,B102-T,N,N,2,NA,4,Bad Prognosis
GSM50074,B104-T,GSM50074,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B104-T,age at dx: 49,tumor size (cm): 2.95,pos lymph nodes: 3,all lymph nodes: 19,path er status: P,path pr status: N,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.32,lm event: 0,lmfs (yr): 7.32,bm event: 0,bmfs (yr): 7.32,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50074/suppl/GSM50074.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50074/suppl/GSM50074.EXP.gz,22283,Reanalyzed by: GSE47561,,49,19,0,0,7.32,N,0,7.32,0,7.32,B104-T,P,N,3,NA,2.95,Good Prognosis
GSM50075,B105-T,GSM50075,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B105-T,age at dx: 49,tumor size (cm): 2.95,pos lymph nodes: 3,all lymph nodes: 19,path er status: P,path pr status: P,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.32,lm event: 0,lmfs (yr): 7.32,bm event: 0,bmfs (yr): 7.32,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50075/suppl/GSM50075.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50075/suppl/GSM50075.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,49,19,0,0,7.32,N,0,7.32,0,7.32,B105-T,P,P,3,NA,2.95,Bad Prognosis
GSM50076,B106-T,GSM50076,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B106-T,age at dx: 57,tumor size (cm): 2.1,pos lymph nodes: 2,all lymph nodes: 16,path er status: P,path pr status: P,her2 status: N,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50076/suppl/GSM50076.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50076/suppl/GSM50076.EXP.gz,22283,Reanalyzed by: GSE47561,,57,16,--,--,--,N,--,--,--,--,B106-T,P,P,2,NA,2.1,--
GSM50077,B107-T,GSM50077,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B107-T,age at dx: 57,tumor size (cm): 2.1,pos lymph nodes: 2,all lymph nodes: 16,path er status: P,path pr status: P,her2 status: N,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50077/suppl/GSM50077.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50077/suppl/GSM50077.EXP.gz,22283,Reanalyzed by: GSE47561,,57,16,--,--,--,N,--,--,--,--,B107-T,P,P,2,NA,2.1,--
GSM50078,B112-T,GSM50078,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B112-T,age at dx: 41,tumor size (cm): 4,pos lymph nodes: 1,all lymph nodes: 20,path er status: N,path pr status: P,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.98,lm event: 0,lmfs (yr): 6.98,bm event: 0,bmfs (yr): 6.98,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50078/suppl/GSM50078.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50078/suppl/GSM50078.EXP.gz,22283,Reanalyzed by: GSE47561,,41,20,0,0,6.98,N,0,6.98,0,6.98,B112-T,N,P,1,NA,4,Bad Prognosis
GSM50079,B115-T,GSM50079,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B115-T,age at dx: 40,tumor size (cm): 5,pos lymph nodes: 3,all lymph nodes: 16,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.52,lm event: 0,lmfs (yr): 6.52,bm event: 0,bmfs (yr): 6.52,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50079/suppl/GSM50079.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50079/suppl/GSM50079.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,40,16,0,0,6.52,N,0,6.52,0,6.52,B115-T,N,N,3,NA,5,Bad Prognosis
GSM50080,B78-T,GSM50080,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B78-T,age at dx: 41,tumor size (cm): 2,pos lymph nodes: 2,all lymph nodes: 28,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.25,lm event: 0,lmfs (yr): 7.25,bm event: 0,bmfs (yr): 7.25,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50080/suppl/GSM50080.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50080/suppl/GSM50080.EXP.gz,22283,Reanalyzed by: GSE47561,,41,28,0,0,7.25,N,0,7.25,0,7.25,B78-T,P,P,2,NA,2,Good Prognosis
GSM50081,B79-T,GSM50081,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B79-T,age at dx: 81,tumor size (cm): 2.4,pos lymph nodes: 1,all lymph nodes: 12,path er status: P,path pr status: P,her2 status: --,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 5.07,lm event: 0,lmfs (yr): 5.07,bm event: 0,bmfs (yr): 5.07,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50081/suppl/GSM50081.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50081/suppl/GSM50081.EXP.gz,22283,Reanalyzed by: GSE47561,,81,12,0,0,5.07,--,0,5.07,0,5.07,B79-T,P,P,1,NA,2.4,Good Prognosis
GSM50082,B80-T,GSM50082,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B80-T,age at dx: 49,tumor size (cm): 2.2,pos lymph nodes: 3,all lymph nodes: 37,path er status: P,path pr status: P,her2 status: 2+,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.11,lm event: 0,lmfs (yr): 7.11,bm event: 0,bmfs (yr): 7.11,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50082/suppl/GSM50082.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50082/suppl/GSM50082.EXP.gz,22283,Reanalyzed by: GSE47561,,49,37,0,0,7.11,2+,0,7.11,0,7.11,B80-T,P,P,3,NA,2.2,Good Prognosis
GSM50083,B82-T,GSM50083,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B82-T,age at dx: 61,tumor size (cm): 2.5,pos lymph nodes: 1,all lymph nodes: 21,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.28,lm event: 0,lmfs (yr): 7.28,bm event: 0,bmfs (yr): 7.28,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50083/suppl/GSM50083.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50083/suppl/GSM50083.EXP.gz,22283,Reanalyzed by: GSE47561,,61,21,0,0,7.28,N,0,7.28,0,7.28,B82-T,P,P,1,NA,2.5,Good Prognosis
GSM50084,B83-T,GSM50084,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B83-T,age at dx: 39,tumor size (cm): 4,pos lymph nodes: 1,all lymph nodes: 23,path er status: P,path pr status: P,her2 status: 1+,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.40,lm event: 0,lmfs (yr): 6.40,bm event: 0,bmfs (yr): 6.40,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50084/suppl/GSM50084.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50084/suppl/GSM50084.EXP.gz,22283,Reanalyzed by: GSE47561,,39,23,0,0,6.40,1+,0,6.40,0,6.40,B83-T,P,P,1,NA,4,Good Prognosis
GSM50085,B84-T,GSM50085,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B84-T,age at dx: 37,tumor size (cm): 2.3,pos lymph nodes: 3,all lymph nodes: 22,path er status: P,path pr status: P,her2 status: 2+,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.50,lm event: 0,lmfs (yr): 6.50,bm event: 0,bmfs (yr): 6.50,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50085/suppl/GSM50085.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50085/suppl/GSM50085.EXP.gz,22283,Reanalyzed by: GSE47561,,37,22,0,0,6.50,2+,0,6.50,0,6.50,B84-T,P,P,3,NA,2.3,Good Prognosis
GSM50086,B85-T,GSM50086,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B85-T,age at dx: 57,tumor size (cm): 4.3,pos lymph nodes: 1,all lymph nodes: 18,path er status: P,path pr status: N,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 8.31,lm event: 0,lmfs (yr): 8.31,bm event: 0,bmfs (yr): 8.31,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50086/suppl/GSM50086.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50086/suppl/GSM50086.EXP.gz,22283,Reanalyzed by: GSE47561,,57,18,0,0,8.31,N,0,8.31,0,8.31,B85-T,P,N,1,NA,4.3,Good Prognosis
GSM50087,B86-T,GSM50087,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B86-T,age at dx: 57,tumor size (cm): 4.3,pos lymph nodes: 1,all lymph nodes: 18,path er status: P,path pr status: N,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 8.31,lm event: 0,lmfs (yr): 8.31,bm event: 0,bmfs (yr): 8.31,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50087/suppl/GSM50087.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50087/suppl/GSM50087.EXP.gz,22283,Reanalyzed by: GSE47561,,57,18,0,0,8.31,N,0,8.31,0,8.31,B86-T,P,N,1,NA,4.3,Good Prognosis
GSM50088,B87-T,GSM50088,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B87-T,age at dx: 51,tumor size (cm): 2.5,pos lymph nodes: 1,all lymph nodes: 17,path er status: P,path pr status: N,her2 status: 3+,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50088/suppl/GSM50088.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50088/suppl/GSM50088.EXP.gz,22283,Reanalyzed by: GSE47561,,51,17,--,--,--,3+,--,--,--,--,B87-T,P,N,1,NA,2.5,--
GSM50089,B89-T,GSM50089,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B89-T,age at dx: 30,tumor size (cm): 3,pos lymph nodes: 3,all lymph nodes: 30,path er status: N,path pr status: N,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 8.74,lm event: 0,lmfs (yr): 8.74,bm event: 0,bmfs (yr): 8.74,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50089/suppl/GSM50089.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50089/suppl/GSM50089.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,30,30,0,0,8.74,N,0,8.74,0,8.74,B89-T,N,N,3,NA,3,Good Prognosis
GSM50090,B90-T,GSM50090,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B90-T,age at dx: 34,tumor size (cm): 4.3,pos lymph nodes: 1,all lymph nodes: 21,path er status: P,path pr status: P,her2 status: --,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.79,lm event: 0,lmfs (yr): 6.79,bm event: 0,bmfs (yr): 6.79,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50090/suppl/GSM50090.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50090/suppl/GSM50090.EXP.gz,22283,Reanalyzed by: GSE47561,,34,21,0,0,6.79,--,0,6.79,0,6.79,B90-T,P,P,1,NA,4.3,Good Prognosis
GSM50091,B91-T,GSM50091,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B91-T,age at dx: 84,tumor size (cm): 10,pos lymph nodes: 2,all lymph nodes: 11,path er status: P,path pr status: N,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.19,lm event: 0,lmfs (yr): 7.19,bm event: 0,bmfs (yr): 7.19,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50091/suppl/GSM50091.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50091/suppl/GSM50091.EXP.gz,22283,Reanalyzed by: GSE47561,,84,11,0,0,7.19,N,0,7.19,0,7.19,B91-T,P,N,2,NA,10,Good Prognosis
GSM50092,B93-T,GSM50092,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B93-T,age at dx: 50,tumor size (cm): 2.3,pos lymph nodes: 1,all lymph nodes: 29,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.45,lm event: 0,lmfs (yr): 6.45,bm event: 0,bmfs (yr): 6.45,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50092/suppl/GSM50092.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50092/suppl/GSM50092.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,50,29,0,0,6.45,N,0,6.45,0,6.45,B93-T,N,N,1,NA,2.3,Bad Prognosis
GSM50093,B97-T,GSM50093,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B97-T,age at dx: 64,tumor size (cm): 2,pos lymph nodes: 2,all lymph nodes: 20,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.86,lm event: 0,lmfs (yr): 7.86,bm event: 0,bmfs (yr): 7.86,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50093/suppl/GSM50093.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50093/suppl/GSM50093.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,64,20,0,0,7.86,N,0,7.86,0,7.86,B97-T,N,N,2,NA,2,Bad Prognosis
GSM50094,B103-T,GSM50094,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B103-T,age at dx: 57,tumor size (cm): 1.3,pos lymph nodes: 3,all lymph nodes: 15,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 3.22,lm event: 1,lmfs (yr): 3.22,bm event: 1,bmfs (yr): 3.65,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50094/suppl/GSM50094.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50094/suppl/GSM50094.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,57,15,1,1,3.65,N,1,3.22,1,3.22,B103-T,N,N,3,NA,1.3,Bad Prognosis
GSM50095,B108-T,GSM50095,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B108-T,age at dx: 54,tumor size (cm): 2.6,pos lymph nodes: 1,all lymph nodes: 29,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 1,mfs (yr): 6.54,lm event: 0,lmfs (yr): 7.46,bm event: 0,bmfs (yr): 7.46,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50095/suppl/GSM50095.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50095/suppl/GSM50095.EXP.gz,22283,Reanalyzed by: GSE47561,,54,29,0,0,7.46,N,0,7.46,1,6.54,B108-T,P,P,1,NA,2.6,Good Prognosis
GSM50096,B109-T,GSM50096,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B109-T,age at dx: 32,tumor size (cm): 6,pos lymph nodes: 2,all lymph nodes: 32,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 1.38,lm event: 1,lmfs (yr): 1.38,bm event: 0,bmfs (yr): 1.67,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50096/suppl/GSM50096.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50096/suppl/GSM50096.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,32,32,1,0,1.67,N,1,1.38,1,1.38,B109-T,N,N,2,NA,6,Bad Prognosis
GSM50097,B111-T,GSM50097,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B111-T,age at dx: 46,tumor size (cm): 1.3,pos lymph nodes: 2,all lymph nodes: 22,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 1,mfs (yr): 5.39,lm event: 0,lmfs (yr): 7.11,bm event: 1,bmfs (yr): 5.39,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50097/suppl/GSM50097.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50097/suppl/GSM50097.EXP.gz,22283,Reanalyzed by: GSE47561,,46,22,0,1,5.39,N,0,7.11,1,5.39,B111-T,P,P,2,NA,1.3,Good Prognosis
GSM50098,B113-T,GSM50098,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B113-T,age at dx: 49,tumor size (cm): 1.5,pos lymph nodes: 3,all lymph nodes: 22,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 2.57,lm event: 0,lmfs (yr): 7.53,bm event: 1,bmfs (yr): 2.57,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50098/suppl/GSM50098.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50098/suppl/GSM50098.EXP.gz,22283,Reanalyzed by: GSE47561,,49,22,1,1,2.57,N,0,7.53,1,2.57,B113-T,P,P,3,NA,1.5,Good Prognosis
GSM50099,B81-T,GSM50099,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B81-T,age at dx: 31,tumor size (cm): 2.5,pos lymph nodes: 5,all lymph nodes: 10,path er status: P,path pr status: P,her2 status: --,van't veer signature: Good Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 1.30,lm event: 0,lmfs (yr): 5.68,bm event: 1,bmfs (yr): 1.30,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50099/suppl/GSM50099.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50099/suppl/GSM50099.EXP.gz,22283,Reanalyzed by: GSE47561,,31,10,1,1,1.30,--,0,5.68,1,1.30,B81-T,P,P,5,NA,2.5,Good Prognosis
GSM50100,B88-T,GSM50100,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B88-T,age at dx: 61,tumor size (cm): 4.8,pos lymph nodes: 1,all lymph nodes: 15,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 1,mfs (yr): 5.81,lm event: 0,lmfs (yr): 7.96,bm event: 0,bmfs (yr): 7.96,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50100/suppl/GSM50100.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50100/suppl/GSM50100.EXP.gz,22283,Reanalyzed by: GSE47561,,61,15,0,0,7.96,N,0,7.96,1,5.81,B88-T,P,P,1,NA,4.8,Good Prognosis
GSM50101,B92-T,GSM50101,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B92-T,age at dx: 72,tumor size (cm): 2.5,pos lymph nodes: 3,all lymph nodes: 19,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 1,mfs (yr): 6.36,lm event: 0,lmfs (yr): 7.58,bm event: 1,bmfs (yr): 6.36,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50101/suppl/GSM50101.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50101/suppl/GSM50101.EXP.gz,22283,Reanalyzed by: GSE47561,,72,19,0,1,6.36,N,0,7.58,1,6.36,B92-T,P,P,3,NA,2.5,Good Prognosis
GSM50102,B94-T,GSM50102,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B94-T,age at dx: 48,tumor size (cm): 4,pos lymph nodes: 1,all lymph nodes: 18,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 0.67,lm event: 0,lmfs (yr): 1.03,bm event: 0,bmfs (yr): 1.03,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50102/suppl/GSM50102.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50102/suppl/GSM50102.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,48,18,1,0,1.03,N,0,1.03,1,0.67,B94-T,N,N,1,NA,4,Bad Prognosis
GSM50103,B95-T,GSM50103,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B95-T,age at dx: 61,tumor size (cm): 3.8,pos lymph nodes: 3,all lymph nodes: 19,path er status: N,path pr status: N,her2 status: 3+,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 1.84,lm event: 1,lmfs (yr): 1.84,bm event: 0,bmfs (yr): 1.84,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50103/suppl/GSM50103.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50103/suppl/GSM50103.EXP.gz,22283,Reanalyzed by: GSE47561,,61,19,1,0,1.84,3+,1,1.84,1,1.84,B95-T,N,N,3,NA,3.8,Bad Prognosis
GSM50104,B96-T,GSM50104,Public on Jul 28 2005,May 03 2005,Nov 30 2010,RNA,1,Primary Breast Cancer,Homo sapiens,name: B96-T,age at dx: 65,tumor size (cm): 2.9,pos lymph nodes: 1,all lymph nodes: 18,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 1,mfs (yr): 6.77,lm event: 0,lmfs (yr): 8.89,bm event: 1,bmfs (yr): 6.77,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50104/suppl/GSM50104.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50104/suppl/GSM50104.EXP.gz,22283,,,65,18,0,1,6.77,N,0,8.89,1,6.77,B96-T,P,P,1,NA,2.9,Good Prognosis
GSM50105,B99-T,GSM50105,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B99-T,age at dx: 54,tumor size (cm): 4.5,pos lymph nodes: 1,all lymph nodes: 19,path er status: P,path pr status: N,her2 status: --,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.19,lm event: 0,lmfs (yr): 7.19,bm event: 0,bmfs (yr): 7.19,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50105/suppl/GSM50105.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50105/suppl/GSM50105.EXP.gz,22283,Reanalyzed by: GSE47561,,54,19,0,0,7.19,--,0,7.19,0,7.19,B99-T,P,N,1,NA,4.5,Good Prognosis
GSM50106,B7-T,GSM50106,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B7-T,age at dx: 60,tumor size (cm): 10,pos lymph nodes: 15,all lymph nodes: 26,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 1.58,lm event: 1,lmfs (yr): 1.58,bm event: 0,bmfs (yr): 1.65,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50106/suppl/GSM50106.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50106/suppl/GSM50106.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,60,26,1,0,1.65,N,1,1.58,1,1.58,B7-T,N,N,15,NA,10,Bad Prognosis
GSM50107,B10-T,GSM50107,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B10-T,age at dx: 52,tumor size (cm): 6.5,pos lymph nodes: 8,all lymph nodes: 9,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.21,lm event: 0,lmfs (yr): 6.21,bm event: 0,bmfs (yr): 6.21,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50107/suppl/GSM50107.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50107/suppl/GSM50107.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,52,9,0,0,6.21,N,0,6.21,0,6.21,B10-T,N,N,8,NA,6.5,Bad Prognosis
GSM50108,B11-T,GSM50108,Public on Jul 28 2005,May 03 2005,Nov 30 2010,RNA,1,Primary Breast Cancer,Homo sapiens,name: B11-T,age at dx: 52,tumor size (cm): 1.8,pos lymph nodes: 12,all lymph nodes: 33,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 3.96,lm event: 0,lmfs (yr): 3.96,bm event: 0,bmfs (yr): 3.96,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50108/suppl/GSM50108.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50108/suppl/GSM50108.EXP.gz,22283,,,52,33,--,0,3.96,N,0,3.96,0,3.96,B11-T,P,P,12,NA,1.8,Good Prognosis
GSM50109,B12-T,GSM50109,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B12-T,age at dx: 57,tumor size (cm): 2,pos lymph nodes: 1,all lymph nodes: 21,path er status: P,path pr status: P,her2 status: --,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50109/suppl/GSM50109.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50109/suppl/GSM50109.EXP.gz,22283,Reanalyzed by: GSE47561,,57,21,--,--,--,--,--,--,--,--,B12-T,P,P,1,NA,2,--
GSM50110,B13-T,GSM50110,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B13-T,age at dx: 44,tumor size (cm): 6.1,pos lymph nodes: 1,all lymph nodes: 15,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 5.19,lm event: 0,lmfs (yr): 5.19,bm event: 0,bmfs (yr): 5.19,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50110/suppl/GSM50110.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50110/suppl/GSM50110.EXP.gz,22283,Reanalyzed by: GSE47561,,44,15,0,0,5.19,N,0,5.19,0,5.19,B13-T,N,N,1,NA,6.1,Bad Prognosis
GSM50111,B14-T,GSM50111,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B14-T,age at dx: 61,tumor size (cm): 5,pos lymph nodes: 30,all lymph nodes: 33,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 7.30,lm event: 0,lmfs (yr): 7.30,bm event: 0,bmfs (yr): 7.30,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50111/suppl/GSM50111.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50111/suppl/GSM50111.EXP.gz,22283,Reanalyzed by: GSE47561,,61,33,0,0,7.30,N,0,7.30,0,7.30,B14-T,P,P,30,NA,5,Good Prognosis
GSM50112,B15-T,GSM50112,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B15-T,age at dx: 43,tumor size (cm): 4.5,pos lymph nodes: 1,all lymph nodes: 21,path er status: P,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 1.18,lm event: 1,lmfs (yr): 1.18,bm event: 1,bmfs (yr): 1.18,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50112/suppl/GSM50112.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50112/suppl/GSM50112.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,43,21,1,1,1.18,N,1,1.18,1,1.18,B15-T,P,N,1,NA,4.5,Bad Prognosis
GSM50113,B16-T,GSM50113,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B16-T,age at dx: 56,tumor size (cm): 2.6,pos lymph nodes: 5,all lymph nodes: 26,path er status: P,path pr status: P,her2 status: 1+,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50113/suppl/GSM50113.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50113/suppl/GSM50113.EXP.gz,22283,Reanalyzed by: GSE47561,,56,26,--,--,--,1+,--,--,--,--,B16-T,P,P,5,NA,2.6,--
GSM50114,B17-T,GSM50114,Public on Jul 28 2005,May 03 2005,Nov 30 2010,RNA,1,Primary Breast Cancer,Homo sapiens,name: B17-T,age at dx: 62,tumor size (cm): 3.5,pos lymph nodes: 20,all lymph nodes: 21,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 1.30,lm event: 0,lmfs (yr): 1.30,bm event: 1,bmfs (yr): 1.30,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50114/suppl/GSM50114.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50114/suppl/GSM50114.EXP.gz,22283,,,62,21,1,1,1.30,N,0,1.30,1,1.30,B17-T,P,P,20,NA,3.5,Good Prognosis
GSM50115,B18-T,GSM50115,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B18-T,age at dx: 40,tumor size (cm): 3.5,pos lymph nodes: 17,all lymph nodes: 26,path er status: P,path pr status: P,her2 status: N,van't veer signature: Good Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 4.42,lm event: 0,lmfs (yr): 4.42,bm event: 0,bmfs (yr): 4.42,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50115/suppl/GSM50115.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50115/suppl/GSM50115.EXP.gz,22283,Reanalyzed by: GSE47561,,40,26,--,0,4.42,N,0,4.42,0,4.42,B18-T,P,P,17,NA,3.5,Good Prognosis
GSM50116,B1-T,GSM50116,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B1-T,age at dx: 65,tumor size (cm): 7.5,pos lymph nodes: 4,all lymph nodes: 19,path er status: N,path pr status: N,her2 status: 2+,van't veer signature: Bad Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 3.58,lm event: 0,lmfs (yr): 3.58,bm event: 0,bmfs (yr): 3.58,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50116/suppl/GSM50116.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50116/suppl/GSM50116.EXP.gz,22283,Reanalyzed by: GSE47561,,65,19,--,0,3.58,2+,0,3.58,0,3.58,B1-T,N,N,4,NA,7.5,Bad Prognosis
GSM50117,B23-T,GSM50117,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B23-T,age at dx: 38,tumor size (cm): 1.5,pos lymph nodes: 17,all lymph nodes: 17,path er status: P,path pr status: P,her2 status: 3+,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50117/suppl/GSM50117.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50117/suppl/GSM50117.EXP.gz,22283,Reanalyzed by: GSE47561,,38,17,--,--,--,3+,--,--,--,--,B23-T,P,P,17,NA,1.5,--
GSM50118,B24-T,GSM50118,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B24-T,age at dx: 72,tumor size (cm): 3,pos lymph nodes: 5,all lymph nodes: 23,path er status: P,path pr status: P,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 6.28,lm event: 0,lmfs (yr): 6.28,bm event: 0,bmfs (yr): 6.28,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50118/suppl/GSM50118.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50118/suppl/GSM50118.EXP.gz,22283,Reanalyzed by: GSE47561,,72,23,0,0,6.28,N,0,6.28,0,6.28,B24-T,P,P,5,NA,3,Bad Prognosis
GSM50119,B26-T,GSM50119,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B26-T,age at dx: 54,tumor size (cm): 4,pos lymph nodes: 7,all lymph nodes: 31,path er status: N,path pr status: N,her2 status: 1+,van't veer signature: Bad Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 4.18,lm event: 0,lmfs (yr): 4.18,bm event: 0,bmfs (yr): 4.18,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50119/suppl/GSM50119.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50119/suppl/GSM50119.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,54,31,--,0,4.18,1+,0,4.18,0,4.18,B26-T,N,N,7,NA,4,Bad Prognosis
GSM50120,B27-T,GSM50120,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B27-T,age at dx: 38,tumor size (cm): 4.1,pos lymph nodes: 5,all lymph nodes: 31,path er status: P,path pr status: P,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 3.68,lm event: 0,lmfs (yr): 3.68,bm event: 0,bmfs (yr): 3.68,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50120/suppl/GSM50120.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50120/suppl/GSM50120.EXP.gz,22283,Reanalyzed by: GSE47561,,38,31,--,0,3.68,N,0,3.68,0,3.68,B27-T,P,P,5,NA,4.1,Bad Prognosis
GSM50121,B28-T,GSM50121,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B28-T,age at dx: 54,tumor size (cm): 6,pos lymph nodes: 6,all lymph nodes: 27,path er status: P,path pr status: P,her2 status: 1+,van't veer signature: Good Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 4.12,lm event: 0,lmfs (yr): 4.12,bm event: 0,bmfs (yr): 4.12,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50121/suppl/GSM50121.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50121/suppl/GSM50121.EXP.gz,22283,Reanalyzed by: GSE47561,,54,27,--,0,4.12,1+,0,4.12,0,4.12,B28-T,P,P,6,NA,6,Good Prognosis
GSM50122,B29-T,GSM50122,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B29-T,age at dx: 43,tumor size (cm): 8,pos lymph nodes: 22,all lymph nodes: 36,path er status: P,path pr status: P,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 3.24,lm event: 0,lmfs (yr): 4.07,bm event: 1,bmfs (yr): 3.24,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50122/suppl/GSM50122.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50122/suppl/GSM50122.EXP.gz,22283,Reanalyzed by: GSE47561,,43,36,1,1,3.24,N,0,4.07,1,3.24,B29-T,P,P,22,NA,8,Bad Prognosis
GSM50123,B2-T,GSM50123,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B2-T,age at dx: 59,tumor size (cm): 4.5,pos lymph nodes: 10,all lymph nodes: 21,path er status: N,path pr status: N,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 3.90,lm event: 0,lmfs (yr): 3.90,bm event: 0,bmfs (yr): 3.90,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50123/suppl/GSM50123.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50123/suppl/GSM50123.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,59,21,--,0,3.90,N,0,3.90,0,3.90,B2-T,N,N,10,NA,4.5,Bad Prognosis
GSM50124,B31-T,GSM50124,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B31-T,age at dx: 87,tumor size (cm): 2.9,pos lymph nodes: 2,all lymph nodes: 20,path er status: P,path pr status: P,her2 status: N,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50124/suppl/GSM50124.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50124/suppl/GSM50124.EXP.gz,22283,Reanalyzed by: GSE47561,,87,20,--,--,--,N,--,--,--,--,B31-T,P,P,2,NA,2.9,--
GSM50125,B32-T,GSM50125,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B32-T,age at dx: 59,tumor size (cm): 7,pos lymph nodes: 1,all lymph nodes: 17,path er status: N,path pr status: N,her2 status: 1+,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50125/suppl/GSM50125.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50125/suppl/GSM50125.EXP.gz,22283,Reanalyzed by: GSE31519,Reanalyzed by: GSE47561,59,17,--,--,--,1+,--,--,--,--,B32-T,N,N,1,NA,7,--
GSM50126,B33-T,GSM50126,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B33-T,age at dx: 38,tumor size (cm): 3.5,pos lymph nodes: 2,all lymph nodes: 16,path er status: P,path pr status: P,her2 status: 3+,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50126/suppl/GSM50126.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50126/suppl/GSM50126.EXP.gz,22283,Reanalyzed by: GSE47561,,38,16,--,--,--,3+,--,--,--,--,B33-T,P,P,2,NA,3.5,--
GSM50127,B3-T,GSM50127,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B3-T,age at dx: 59,tumor size (cm): 6,pos lymph nodes: 4,all lymph nodes: 29,path er status: P,path pr status: P,her2 status: 1+ (only 1 core pos.),van't veer signature: Bad Prognosis,binary 5y met event: 0,met event: 0,mfs (yr): 5.24,lm event: 0,lmfs (yr): 5.24,bm event: 0,bmfs (yr): 5.24,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50127/suppl/GSM50127.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50127/suppl/GSM50127.EXP.gz,22283,Reanalyzed by: GSE47561,,59,29,0,0,5.24,1+ (only 1 core pos.),0,5.24,0,5.24,B3-T,P,P,4,NA,6,Bad Prognosis
GSM50128,B4-T,GSM50128,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B4-T,age at dx: 70,tumor size (cm): 3,pos lymph nodes: 6,all lymph nodes: 11,path er status: P,path pr status: P,her2 status: 1+,van't veer signature: Good Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 2.30,lm event: 0,lmfs (yr): 2.30,bm event: 0,bmfs (yr): 2.30,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50128/suppl/GSM50128.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50128/suppl/GSM50128.EXP.gz,22283,Reanalyzed by: GSE47561,,70,11,--,0,2.30,1+,0,2.30,0,2.30,B4-T,P,P,6,NA,3,Good Prognosis
GSM50129,B5-T,GSM50129,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B5-T,age at dx: 39,tumor size (cm): 6,pos lymph nodes: 6,all lymph nodes: 22,path er status: P,path pr status: N,her2 status: --,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50129/suppl/GSM50129.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50129/suppl/GSM50129.EXP.gz,22283,Reanalyzed by: GSE47561,,39,22,--,--,--,--,--,--,--,--,B5-T,P,N,6,NA,6,--
GSM50130,B6-T,GSM50130,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B6-T,age at dx: 54,tumor size (cm): 3,pos lymph nodes: 18,all lymph nodes: 23,path er status: N,path pr status: N,her2 status: 3+,van't veer signature: Bad Prognosis,binary 5y met event: --,met event: 0,mfs (yr): 3.36,lm event: 0,lmfs (yr): 3.36,bm event: 0,bmfs (yr): 3.36,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50130/suppl/GSM50130.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50130/suppl/GSM50130.EXP.gz,22283,Reanalyzed by: GSE47561,,54,23,--,0,3.36,3+,0,3.36,0,3.36,B6-T,N,N,18,NA,3,Bad Prognosis
GSM50131,B8-T,GSM50131,Public on Jul 28 2005,May 03 2005,May 31 2013,RNA,1,Primary Breast Cancer,Homo sapiens,name: B8-T,age at dx: 42,tumor size (cm): 3.9,pos lymph nodes: 24,all lymph nodes: 28,path er status: P,path pr status: P,her2 status: N,van't veer signature: Bad Prognosis,binary 5y met event: 1,met event: 1,mfs (yr): 4.59,lm event: 0,lmfs (yr): 6.05,bm event: 1,bmfs (yr): 4.59,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50131/suppl/GSM50131.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50131/suppl/GSM50131.EXP.gz,22283,Reanalyzed by: GSE47561,,42,28,1,1,4.59,N,0,6.05,1,4.59,B8-T,P,P,24,NA,3.9,Bad Prognosis
GSM50132,B9-T,GSM50132,Public on Jul 28 2005,May 03 2005,Nov 30 2010,RNA,1,Primary Breast Cancer,Homo sapiens,name: B9-T,age at dx: 74,tumor size (cm): 3.9,pos lymph nodes: 29,all lymph nodes: 31,path er status: P,path pr status: N,her2 status: N,van't veer signature: --,binary 5y met event: --,met event: --,mfs (yr): --,lm event: --,lmfs (yr): --,bm event: --,bmfs (yr): --,total RNA,RNA was extracted using a Qiagen RNeasy kit from homogenized frozen tumors,biotin,Standard Affymetrix protocol,9606,Standard Affymetrix protocol,Standard Affymetrix protocol,RNA was extracted using a Quiagen RNeasy kit from homogenized frozen tumors,,,MAS 5.0,GPL96,"Agnes,,Viale",vialea@mskcc.org,212 639 3031,212 717 3053,Genomics Core Laboratory,Molecular Biology,Memorial Sloan Kettering Cancer Center,1275 York Avenue,New York,NY,10021,USA,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50132/suppl/GSM50132.CEL.gz,ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM50nnn/GSM50132/suppl/GSM50132.EXP.gz,22283,,,74,31,--,--,--,N,--,--,--,--,B9-T,P,N,29,NA,3.9,--
